Literature DB >> 3336097

Angiomyolipoma: clinical metamorphosis and concepts for management.

M L Blute1, R S Malek, J W Segura.   

Abstract

In 10 years the diagnosis of renal angiomyolipoma was made in 44 patients (female-to-male ratio 8:1) at our institution; 4 cases were associated with tuberous sclerosis. Of these patients 29 underwent surgical exploration because of a renal mass; 11 patients with renal masses that were consistent with angiomyolipoma radiologically have not undergone exploration. Of the 4 patients with and the 29 patients without tuberous sclerosis 1 (25 per cent) and 2 (7 per cent), respectively, had renal cell cancer in association with angiomyolipoma. Metachronous involvement of the contralateral kidney has not been noted in any of our patients who underwent nephrectomy for unilateral involvement, nor has there been progression of the contralateral lesion in 3 patients with bilateral disease without tuberous sclerosis during a followup of about 6 years. Furthermore, we have not noted progression of lesions in the 11 patients under observation for a mean followup of almost 3 years. We recommend elective exploration and a renal preserving operation when possible, not only for patients with pain and hemorrhage but also for the complex multiple lesions occasionally seen in patients who do not have tuberous sclerosis. Lesions associated with tuberous sclerosis require surgical intervention only when they become symptomatic or enlarge silently.

Entities:  

Mesh:

Year:  1988        PMID: 3336097     DOI: 10.1016/s0022-5347(17)42276-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  [Massive bleeding of the urogenital tract].

Authors:  C-A J von Klot; R Fricke; M A Kuczyk; H Tezval
Journal:  Internist (Berl)       Date:  2017-03       Impact factor: 0.743

2.  A case of a cutaneous angiomyolipoma.

Authors:  Jung-U Shin; Kyu-Yeoop Lee; Mi Ryung Roh
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

3.  Giant angiomyolipoma associated with marked pulmonary lesions suggesting lymphangioleiomyomatosis in a patient with tuberous sclerosis.

Authors:  E Tüzel; Z Kirkali; U Mungan; C Cüler; M Sade
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

4.  Ileal angiomyolipoma manifested by small intestinal intussusception.

Authors:  Chang Ho Lee; Jong Hun Kim; Doo Hyun Yang; Yong Hwang; Myoung Jae Kang; Young Kon Kim; Min Ro Lee
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

5.  [Angiomyolipoma of the kidneys as a rare cause of retroperitoneal hemorrhage. Two case reports with tuberous sclerosis Bourneville-Pringle].

Authors:  M May; M Seehafer; C Helke; P Stosiek; C Ehlers; B Hoschke
Journal:  Urologe A       Date:  2003-02-07       Impact factor: 0.639

6.  Renal involvement in tuberous sclerosis complex: a retrospective survey.

Authors:  L B Zimmerhackl; M Rehm; K Kaufmehl; G Kurlemann; M Brandis
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

7.  Renal angiomyolipoma presenting with massive retroperitoneal haemorrhage due to deranged clotting factors: a case report.

Authors:  Timothy Wright; Prasanna Sooriakumaran
Journal:  Cases J       Date:  2008-10-04

8.  Wunderlich's syndrome in spontaneous angiomyolipoma bleeding.

Authors:  G H Neild; Chun-Yu Lin; Yih-Huei Lin; Fu-Zong Wu; Huay-Ben Pan
Journal:  NDT Plus       Date:  2011-03-01

9.  Implications of computer tomography measurement in the management of renal tumours.

Authors:  Rahul Mistry; Ramaswamy Manikandan; Penny Williams; Joe Philip; Peter Littler; Christopher S Foster; Keith F Parsons
Journal:  BMC Urol       Date:  2008-11-04       Impact factor: 2.264

10.  A Classic Case of Tuberous Sclerosis with Multisystem Involvement Including Giant Bilateral Renal Angiomyolipomas Presenting as Massive Hematuria.

Authors:  Kewal A Mistry; Dinesh Sood; Rohit Bhoil; Veenal Chadha; Ajay K Ahluwalia; Saurabh Sood; Pokhraj P Suthar
Journal:  Pol J Radiol       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.